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ABSTRACT Global poliovirus surveillance involves virus isolation from stool and envi-
ronmental samples, intratypic differential (ITD) by PCR, and sequencing of the VP1 re-
gion to distinguish vaccine (Sabin), vaccine-derived, and wild-type polioviruses and to
ensure an appropriate response. This cell culture algorithm takes 2 to 3weeks on aver-
age between sample receipt and sequencing. Direct detection of viral RNA using PCR al-
lows faster detection but has traditionally faced challenges related to poor sensitivity
and difficulties in sequencing common samples containing poliovirus and enterovirus
mixtures. We present a nested PCR and nanopore sequencing protocol that allows rapid
(3 days) and sensitive direct detection and sequencing of polioviruses in stool and en-
vironmental samples. We developed barcoded primers and a real-time analysis platform
that generate accurate VP1 consensus sequences from multiplexed samples. The sensi-
tivity and specificity of our protocol compared with those of cell culture were 90.9%
(95% confidence interval, 75.7% to 98.1%) and 99.2% (95.5% to 100.0%) for wild-type 1
poliovirus, 92.5% (79.6% to 98.4%) and 98.7% (95.4% to 99.8%) for vaccine and vaccine-
derived serotype 2 poliovirus, and 88.3% (81.2% to 93.5%) and 93.2% (88.6% to 96.3%)
for Sabin 1 and 3 poliovirus alone or in mixtures when tested on 155 stool samples in
Pakistan. Variant analysis of sequencing reads also allowed the identification of poliovi-
ruses and enteroviruses in artificial mixtures and was able to distinguish complex mix-
tures of polioviruses in environmental samples. The median identity of consensus nano-
pore sequences with Sanger or Illumina sequences from the same samples was 99.9%.
This novel method shows promise as a faster and safer alternative to cell culture for the
detection and real-time sequencing of polioviruses in stool and environmental samples.
KEYWORDS enterovirus, environmental surveillance, nanopore sequencing,
poliovirus, stool
Resurgent wild-type poliovirus transmission in Pakistan and Afghanistan and ex-panding outbreaks of vaccine-derived poliovirus (VDPV) in Africa pose the risk of
reversing progress made by the Global Polio Eradication Initiative. Effective control of
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these outbreaks using the oral poliovirus vaccine relies on rapid detection of poliovirus
in stool samples from children with acute flaccid paralysis (AFP) or from environmental
surveillance (ES) samples. Detection of poliovirus is not confirmed until a genetic
sequence from the VP1 region is obtained, which allows circulating virus to be
distinguished from vaccine strains. Identification of serotype 2 VDPV is of particular
importance due to the global withdrawal of serotype 2 oral poliovirus vaccine (OPV) in
April 2016, which has led to a growing cohort of children without immunity to serotype
2 poliovirus (1).
The current gold standard method of poliovirus detection involves culturing the
virus using susceptible cell lines, performing reverse transcription-PCR (RT-PCR) of RNA
extracted from cell culture supernatant to determine serotype, distinguishing Sabin
from non-Sabin polioviruses (intratypic differentiation [ITD]), and subsequent sequenc-
ing by traditional (Sanger) methods (2). However, this method is slow and leads to
delays between sample collection and sequencing result, compromising the speed and
effectiveness of any vaccination response. For example, during 2016 to 2018, the
median time to obtain a sequence needed for case confirmation varied from 3 to 6
weeks in countries in Africa and Asia with VDPV or wild-type poliovirus outbreaks (3).
These delays reflect not only the complex and time-consuming cell culture steps but
also, in many countries, the need to ship samples internationally to laboratories with
sequencing facilities. These methods have other limitations, including challenges re-
lated to biocontainment of poliovirus grown in culture, virus mutation during growth
in cell culture, and competitive exclusion of viruses in samples containing poliovirus
mixtures, leading to a lack of detection of minority or low fitness variants (e.g., ES
samples containing vaccine [Sabin] and vaccine-derived polioviruses).
Direct molecular detection of polioviruses in stool or ES samples using RT-PCR could
allow the rapid detection of poliovirus without the need for cell culture. However,
quantitative RT-PCR capable of amplifying all polioviruses through the use of degen-
erate (pan-poliovirus) primers has historically reported low sensitivity compared with
that of cell culture (4). The use of serotype- or strain-specific primers improves sensi-
tivity, but multiplex assays with many primers would be required to identify all
polioviruses, and the resulting products are too short for informative sequencing (5).
Quantitative PCR in the absence of confirmatory sequencing also risks false-positive
results because of cross-contamination or nonspecific amplification when using degen-
erate primers (6).
A sensitive, nested RT-PCR for the direct detection of polioviruses and other entero-
viruses from clinical material has been developed and recommended by the World
Health Organization (WHO) for enterovirus surveillance, but this method generates only
partial VP1 sequences that cannot be used to confirm poliovirus infection (7). More
recently, a nested RT-PCR based on amplification of the entire capsid region using
pan-enterovirus primers, followed by amplification of the full VP1 using degenerate
pan-poliovirus primers, was shown to be highly sensitive for the detection of poliovirus
in stool (4). However, sequencing of the VP1 RT-PCR product using the traditional
(Sanger) method is problematic for samples containing 1 poliovirus because of its
inability to accurately sequence mixed samples. Similarly, nonspecific amplification of
VP1 from other enteroviruses, which are highly prevalent in stool in low-income
countries and practically ubiquitous in ES samples, limits the applicability of this
approach.
Here, we present a method for the direct detection and identification of polioviruses
from stool and ES samples using a nested PCR followed by nanopore (MinION)
sequencing of the poliovirus VP1 region. This approach allows rapid sequencing library
preparation following RNA extraction (14 h) and subsequent, simultaneous sequenc-
ing of multiple samples using a barcoded DNA library. Sequences are demultiplexed
and analyzed in real-time to provide immediate identification of poliovirus. We vali-
dated the method using artificial mixtures of enteroviruses and assessed sensitivity and
specificity against culture and quantitative PCR using stool and ES samples from
Pakistan and India.
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Creation of artificial virus mixtures.We used virus stocks of Echovirus 7 (E7), Enterovirus-A71 (A71),
Enterovirus-D68 (D68), and serotype 1 Sabin poliovirus (PV1) containing 4.10 109, 4.39 108,
1.26 107, and 4.00 109 median cell culture infectious doses (CCID50s)/ml, respectively. We prepared
an even mixture by adding 20 l of cell culture supernatant of E7, 200 l of EV71, 1,000 l of D68, and
20 l of PV1. To create an uneven sample, we mixed 20 l of each stock and made the volume 500 l.
Sample 3 was a pure culture of PV1, and sample 4 was a trivalent oral poliovirus vaccine standard (8). We
also tested novel oral poliovirus vaccine candidates that have been engineered for greater stability than
the Sabin vaccine (2 candidates for each serotype), including novel serotype 2 vaccine (nOPV2) that is
scheduled for use in response to serotype 2 VDPV outbreaks under WHO Emergency Use Listing in 2020
(9, 10).
Stool and environmental samples. Stool samples were collected during acute flaccid paralysis
(AFP) surveillance in Pakistan between October 2019 and February 2020. These samples are collected
routinely by the Global Polio Eradication Initiative to detect transmission of wild-type poliovirus or VDPVs
that rarely emerge as a result of reversion of the Sabin strains contained within the live-attenuated OPV.
Samples may also contain Sabin strains themselves, originating from the recent use of OPV. We tested
155 samples found to be positive during this period by standard cell culture and ITD for wild-type 1
poliovirus (33); circulating serotype 2 VDPV (12); or Sabin poliovirus serotype, 1, 2, and/or 3 (111).
We additionally tested stored fecal aliquots from 1- to 4-year-old Indian infants participating in a
clinical trial of inactivated poliovirus vaccine conducted in 2013 and who had received bivalent OPV
containing serotype 1 and 3 poliovirus (11). In 2013 and 2014, these samples were tested using a
singleplex reverse transcription-quantitative PCR (qRT-PCR) for Sabin poliovirus 1 and 3 (12) and a subset
by cell culture following the standard WHO protocol (13). We retrieved all 217 samples from this subset
that were positive for serotype 1 or 3 poliovirus by qPCR and 49 randomly selected samples that were
negative by qPCR and culture for inclusion in the current study.
Sewage samples collected by the grab method in 2015 and 2017 in Pakistan were also used. One-liter
raw sewage specimens were processed using two-phase separation to generate sewage concentrate,
followed by the poliovirus isolation cell culture algorithm following WHO guidelines (14). Results from six
culture flasks were amalgamated using aliquots drawn from a single sample (3 ml in total). Sewage
concentrates were also used for direct PCR and sequencing using nanopore, Illumina, or Sanger methods.
Institutional ethics approval was not required because samples are anonymized and free of person-
ally identifiable information. Samples from Pakistan were collected as part of the WHO/Pakistan Gov-
ernment’s official polio surveillance process.
RNA extraction from stool and environmental sample concentrates. Viral RNA extracted from
stool and environmental samples needed to yield long PCR products (4,000 bp). Based on previous
experience with different commercially available RNA extraction kits (see Appendix S1 in the supple-
mental material), we established that both Roche and Qiagen kits were suitable (see Appendix S1). A
Roche kit (catalog number 11858882001) was used for RNA extractions from artificial mixtures and
sewage samples (using 200 l of sewage concentrate as input). For stool samples, 1 g of feces was added
to 5 ml of phosphate-buffered saline (PBS). Chloroform extractions were then performed as described in
reference 13, and 140 l of the suspension was used for RNA extraction using the QIAamp viral RNA
minikit in Pakistan and QIAamp 96 virus QIAcube high-throughput (HT) kit in India.
PCR amplification. PCR products for Sanger, Illumina, and nanopore (MinION) sequencing were
obtained using a combination of protocols. RT-PCR was performed using the Superscript III one-step
RT-PCR system (Invitrogen). cDNA was first synthesized with a single primer being added and the second
primer added for the PCR step. RT-PCR products spanning the enterovirus capsid region or whole
poliovirus genome were generated using primer combinations shown in Data Set S1 and Fig. S1 in the
supplemental material. Poliovirus VP1 products were generated by nested PCR by first amplifying the
capsid region by RT-PCR with pan-enterovirus (pan-EV) primers, followed by a second PCR using
pan-poliovirus (pan-PV) primers Q8/Y7 or Q8/Y7R or serotype-specific VP1 primers (Data Set S1; Fig. S1).
DreamTaq DNA polymerase (Thermo Scientific) or LongAmp Taq polymerase (New England BioLabs
[NEB]) was used for the second PCR.
Sequencing library preparation for nanopore sequencing. As initial tests demonstrated strong
amplification of VP1 using the pan-PV Q8/Y7 primers, we sought to reduce the time and cost for
nanopore sequencing library preparation by modifying these primers with either the addition of a
barcode adaptor (VP1-BCA) or barcode (VP1-barcode) to allow immediate multiplexing of samples (Fig.
1). PCR products underwent a standard preparation for nanopore sequencing with the LSK-109 kit with
barcoding using the EXP-PBC096 kit where necessary. Products amplified with adaptor primers entered
the library preparation protocol at the cleanup step after adaptor ligation. Products amplified with the
barcoded primers entered the protocol at the cleanup step after the barcoding PCR. A complete protocol
is documented in Appendix S2 in the supplemental material and at https://www.protocols.io/groups/
poliovirus-sequencing-consortium. Sequencing was performed on Oxford Nanopore Technologies (ONT)
MinION Mk1B sequencers using R9.4 flow cells. Sequencing run conditions and outputs are described in
Table S1 in the supplemental material.
Pan-EV capsid and pan-PV whole-genome PCR products from the artificial mixtures and ES samples
underwent the standard preparation for nanopore sequencing with the LSK-108 kit with barcoding using
the EXP-PBC001 kit.
Sanger sequencing of poliovirus VP1 nested PCR products. Amplified poliovirus VP1 products
from nested PCR were purified using the QIAquick PCR purification kit (Qiagen) and sequenced using an
ABI Prism 3130 genetic analyzer (Applied Biosystems) using standard protocols.
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Sequence library preparation for Illumina sequencing. Pan-EV capsid and pan-PV VP1 nested PCR
products from ES samples were additionally sequenced using Illumina next-generation sequencing.
Sequencing libraries were prepared using Nextera XT reagents and sequenced on a MiSeq instrument
using a 2 250-mer paired-end v2 flow cell and manufacturer’s protocols (Illumina).
Bioinformatics. Nanopore data were drawn from 20 individual MinION sequencing runs, each of
which is documented in Table S1. Fast5 files were base-called using Albacore v1.8 (pan-PV and pan-EV
experiments) or Guppy v3.4 (remaining experiments) with graphics processing unit (GPU) acceleration on
a Precision 7540 Dell laptop running Ubuntu 18 LTS with 32 GB RAM, a 16 core Intel Xeon central
processing unit (CPU), and Nvidia RTX3000 GPU. Real-time analysis of VP1 reads was performed using a
pipeline customized for the identification and mapping of PV nanopore data and then visualized using
RAMPART (15). Once sufficient coverage of the VP1 region for each demultiplexed sample was confirmed
using RAMPART, consensus sequences were generated from the base-called reads using a custom
pipeline build on a Snakemake framework (16). In brief, reads are binned by sample and matched against
a custom database comprising poliovirus and nonpolio enterovirus (NPEV) VP1 regions drawn from NCBI
Nucleotide (https://www.ncbi.nlm.nih.gov/nuccore/) and the NIAID Virus Pathogen Database and Anal-
ysis Resource (ViPR) (17). To score poliovirus presence, a minimum of 50 reads was required within a bin,
which is above the minimum threshold of sequencing reads required to give an accurate consensus, as
established with simulated data (see Fig. S2 in the supplemental material). A read-correction (“polishing”)
module, which uses mafft v7 (18), minimap2 v2.17 (19), racon v1.4.7 (20), medaka v0.10.0 (21), and
python code for quality control and curation, creates a consensus sequence for each virus population.
The installable, documented pipeline can be found online at https://github.com/polio-nanopore/realtime
-polio.
VDPV and other Sabin-related poliovirus sequences were not included in the VP1 reference database
used by RAMPART because of the potential for spurious matches by nanopore-sequenced Sabin
poliovirus, given the sequencing error rate before polishing and consensus sequence generation.
Instead, sequencing reads with the closest match to the reference Sabin poliovirus VP1 sequences for
each serotype were classified as “Sabin-related’ polioviruses. Consensus sequences were subsequently
generated for these Sabin-related reads to distinguish VDPV from Sabin polioviruses.
We additionally developed a bioinformatics pipeline to distinguish mixtures of polioviruses, including
VDPV and Sabin polioviruses of the same serotype. Raw reads were clustered at 85% identity with
vsearch v2.7.0 (22) and aligned to Sabin references using minimap2 v2.17. Variant calling was performed
within clusters using medaka v0.10.0. Raw reads were then mapped to the variant sites to confirm
linkage, and a maximum likelihood tree of the representative variants was generated using the phangorn
package in R v3.4.3 (23, 24). Trees were cut at a height of 0.1, a consensus sequence for each subtree was
generated, and any identical consensus sequences were merged. Further development of this pipeline
is ongoing and documented online at https://github.com/polio-nanopore/realtime-polio. This same
pipeline was used to detect potential cross-contamination of samples during RNA extraction or PCR that
could result in a mixture of poliovirus reads for a single reaction.
Nanopore sequences from pan-EV capsid and pan-PV complete genome amplicons generated from
artificial mixtures and ES samples were demultiplexed and trimmed using Porechop v0.2.3, and reads
FIG 1 The formulation of primers for MinION sequencing and the entry of the various PCR products into
the sequencing library preparation protocol. In addition to the basic primers, we have tested the addition
of barcode adaptor (BCA) primers or barcodes and flanking regions (BC# primers, with # being the
barcode number with reference to nanopore PCR ligation barcode sequences).
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containing internal adaptors were discarded. Reads were screened to retain only those of the expected
length, ensuring a minimum of 90% coverage (3,650 to 4,200 nucleotides for the capsid and 7,000 to
7,700 nucleotides for the nearly full-length genome). Reads were mapped with blastn (25) to the custom
VP1 database.
Filtered reads from Illumina sequencing of pan-EV and nested VP1 products generated with pan-PV
Q8/Y7 primers were mapped to the VP1 database, and PV consensus sequences were extracted. These
sequence data were processed and analyzed using a custom workflow with the Geneious R10 software
package (Biomatters) as described before (26).
Phylogenetic trees showing the relatedness of VP1 sequences generated using different sequencing
approaches were constructed in MEGAX (27) using the neighbor-joining method from evolutionary
distances estimated under the Tamura-Nei substitution model using the maximum composite likelihood
method (28).
Data availability. Demultiplexed sequencing data are available at the European Nucleotide Archive
under accession number PRJEB37193.
RESULTS
Identification of enteroviruses and polioviruses in artificial mixtures and ES
samples using one-step RT-PCR and nanopore sequencing. Nanopore sequencing
of the enterovirus capsid generated by RT-PCR using pan-EV primers identified all
viruses included in the artificial mixtures, with read counts broadly reflecting the known
composition of the mixtures (Figure 2a). Sabin poliovirus 1 was detected even when the
virus constituted only 0.1% of the viral mixture. Discrepancy between the proportion of
reads by serotype and the known mixture of the even sample may derive from the
pooling of products from the two pan-EV primer sets, with overrepresentation of
species B and D enteroviruses (E7 and EV-D68). Nanopore sequencing of the pan-PV
full-genome product generated by RT-PCR of artificial poliovirus mixtures generated
sequences for nearly the entire genome, with the abundance of reads closely matching
that expected (Figure 2b).
We sequenced pan-EV RT-PCR entire capsid products from eight ES samples
collected in Pakistan during 2015 and 2017 using nanopore and compared them
with assembled reads for the same region generated through Illumina sequencing.
The distribution of enterovirus serotypes was highly similar for the two sequencing
methods (Fig. 3). Poliovirus was found in all eight samples by nanopore sequencing;
yet, attributed reads formed only a small percentage of the total reads (0.002% to
6.65%; median, 0.03%). Whole-capsid poliovirus contigs were produced only for two
of the eight ES samples from the Illumina reads, representing 0.08% and 5.47% of
total reads.
Nested capsid/VP1 PCR barcoded primer development. To increase the specific-
ity and sensitivity of our method, we performed a nested PCR, using pan-EV entire
FIG 2 Identification of enterovirus and poliovirus mixtures by nanopore sequencing of the entire capsid
or full genome. The observed abundance of sequencing reads is compared with that expected based on
the known composition of artificial enteroviruses mixtures (a) and poliovirus mixtures (b). For each
sample, the left bar shows the expected outcome according to the viral titers, and the right bar shows
the observed results through comparison of the sequencing reads with the VP1 database. The results for
sample 2 have been plotted on a log scale.
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capsid RT-PCR with Cre-R and 5=NCR primers in an RT-PCR, followed by pan-PV PCR
using Q8/Y7 VP1 primers (Data Set S1). Modification of the VP1 primers with the
addition of ONT barcodes or the barcode adaptor sequence gave a slight decrease in
sensitivity but was equivalent to the loss of product that occurred during the additional
library preparation steps when using the unadapted primers (see Appendix S3 in the
supplemental material). Equivalence of the VP1-BCA and VP1-barcode primers was
further confirmed by amplification of VP1 from the pan-EV products of 20 ES samples,
which yielded DNA at 25 ng/l suitable for sequencing for 18/20 (90%) and 20/20
(100%) of samples for each primer set, respectively (Fisher’s exact test, P 0.487).
Nested PCR and nanopore sequencing of stool samples. Nested PCR with
barcoded Q8/Y7 primers and nanopore sequencing of the 155 stool samples collected
during 2019 and 2020 in Pakistan detected 90.9% (30/33) of the wild-type 1 polioviruses
that were identified by cell culture and Sanger sequencing, 92.5% (37/40) of serotype
2 Sabin and VDPVs, and 88.3% (106/120) of Sabin 1 and 3 polioviruses (Table 1). One
wild-type poliovirus and one serotype 2 VDPV were detected in samples that were not
positive for these viruses by culture and Sanger sequencing (giving specificities com-
pared with culture of 99.2% and 99.3% for these virus types, respectively). Serotype 1,
2, and 3 Sabin polioviruses were detected in 14 samples that were not positive for these
FIG 3 Enteroviruses present in eight ES samples from Pakistan analyzed by nanopore (N) and Illumina MiSeq (I)
sequencing of pan-EV PCR products. Sequencing reads attributed to the 90% most abundant viruses are shown,
with the remaining identified reads being grouped into “other.” Detections of poliovirus serotypes have been
starred.
TABLE 1 Detection and sequencing of poliovirus in 155 Pakistan stool samples using nanopore sequencing compared with cell culturea
Culture result
Nanopore sequencing results (no. of samples)
Sabin 1 Sabin 2 VDPV2 Sabin 3 Wild-type 1 Sabin 1 3
Sabin 1 Sabin 3
 VDPV2
Wild-type 1
 Sabin 1 Negative
Sabin 1 6 0 0 0 0 4 0 0 1
Sabin 2 0 28 0 0 0 0 0 0 1
VDPV2 0 1 9 0 0 0 0 0 1
Sabin 3 0 0 0 24 1 5 1 0 2
Wild-type 1 0 0 0 0 29 1 0 1 2
Sabin 13 0 0 0 2 0 32 0 0 4
aConcordant results by nanopore sequencing and culture are highlighted in bold.
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viruses by cell culture (specificity, 95.6%). The variant-calling pipeline identified con-
tamination in 16 samples (14 in the last 2 sequencing runs), and these reads were
removed. For the 30 samples where wild-type 1 poliovirus was identified by both
culture and nanopore sequencing, the median identity for the VP1 region was 99.9%
(range, 99.0% to 100%) (Fig. 4). For the samples where serotype 2 Sabin polioviruses or
VDPVs were identified by both methods, the median identity for the VP1 region was
100% (range, 99.8% to 100%).
FIG 4 Relatedness of wild-type serotype 1 polioviruses identified in stool samples in Pakistan using alternative methods. VP1 sequences based on direct PCR
and nanopore sequencing (red) are compared with Sanger-sequenced cell culture isolates (blue).
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Stool samples containing serotype 1 or 3 Sabin poliovirus in India likely had suffered
degradation of viral RNA as a result of storage for 6 years. Nonetheless, 69% (149/217)
yielded 50 reads of the correct virus, and this value increased to 91% (109/120)
among those with at least 100 copies of the target sequence at the time of original
quantitative PCR testing (see Appendix S4 in the supplemental material).
Nested PCR and nanopore sequencing of novel oral poliovirus vaccine candi-
dates. Nested PCR using Q8/Y7 primers generated a VP1 product for all eight novel oral
poliovirus vaccine candidates, and consensus sequences generated from nanopore
reads were 100% identical to Illumina sequences generated for the same samples.
Nested PCR and nanopore sequencing of ES samples. Nanopore sequencing
using nested PCR with pan-PV VP1 Q8/Y7 primers resulted in a median of 87.1% of VP1
enterovirus reads mapping to poliovirus (range, 27.4% to 100.0%) and result in just
6.8% (range, 0.1% to 95.9%) when using the more degenerate Q8/Y7R primer. Con-
sensus building, variant calling, and results from the more specific barcoded Q8/Y7
primers allowed the identification of poliovirus mixtures in these samples, including
wild-type, vaccine (Sabin), and vaccine-derived polioviruses corresponding to different
serotypes (Fig. 5). These results were almost identical to those obtained by Illumina
sequencing of VP1 (Q8/Y7) nested PCR products and Sanger sequencing of VP1 nested
PCR products generated with serotype-specific primers (Fig. 4). Nanopore sequencing
detected eight of nine wild-type 1 polioviruses identified by Sanger or Illumina se-
quencing of direct VP1 products and showed very similar detection of Sabin-related
polioviruses (Pearson’s phi coefficients were 0.89, 1.0, and 1.0 for serotypes 1, 2, and 3,
respectively, for nanopore versus Sanger or Illumina results [which were identical]). In
addition, it was possible to distinguish serotype 2 VDPV and Sabin polioviruses from
nanopore sequencing data using our bioinformatics pipeline, which is not possible for
Sanger or Illumina reads (the latter because they are short and it is difficult to confirm
mutations are shared by a single virus). All three direct detection and sequencing
methods gave somewhat different results from those generated by Sanger sequencing
of cell culture isolates, which is based on combined results of up to 6 positive flasks per
sample, with direct detection identifying fewer polioviruses (e.g., 8 or 9 versus 15
wild-type polioviruses and a lower prevalence of Sabin polioviruses).
Wild-type poliovirus nanopore consensus sequences were nearly identical to those
obtained from the same sample aliquot by serotype-specific VP1 PCR and Sanger or
Illumina sequencing (median identity to Sanger sequences of 100%; range, 99.9% to
100.0%; n 8). These VP1 sequences were also very closely related to those obtained
from corresponding cell culture flasks using Sanger with a median identity of 100.0%
(range, 98.7% to 100.0%) (Fig. 6; see Table S2 in the supplemental material). Similar
results were obtained for Sabin 2 and VDPV2 sequences compared with Sanger or
Illumina sequencing results (median identity to Sanger sequences of 100.0%; range,
99.9% to 100.0%; n 26).
Real-time visualization of demultiplexed sequencing results. The sequencing
data generated through the nested VP1 protocol were analyzed in real-time using
RAMPART (Fig. 7). This analysis included live demultiplexing and mapping of each read
to Sabin or wild-type polioviruses or NPEVs, allowing an immediate decision about
when sufficient reads had been generated for each sample to permit ending of the
sequencing run, preserving the MinION flow cell chemistry for further sequencing runs.
At the end of each run, the custom bioinformatics pipeline created a report for each
sample that describes the number of reads mapping to each reference and the
corresponding consensus sequence.
DISCUSSION
Here, we present a culture-independent method for the rapid detection and se-
quencing of poliovirus from stool and ES samples. Using barcoded primers in a nested
PCR, we were able to proceed from sample to sequence in 3 days, with real-time
identification of polioviruses in each sample during nanopore (MinION) sequencing
using RAMPART (15). The overall sensitivity of this method to detect wild-type or
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vaccine-derived polioviruses in Pakistan was 90% compared with culture, ITD, and
Sanger sequencing methods. Consensus sequences were near identical to those gen-
erated by Sanger sequencing of cell culture isolates for the same samples, indicating
that accurate VP1 sequences can be generated by nanopore sequencing. Further
optimization that we plan for this method has the potential to further increase
sensitivity, such as testing duplicate extractions from a single stool sample and use of
an RNA extraction control (e.g., bacteriophage Q).
Immediate identification of the poliovirus sequence allows downstream phyloge-
netic analysis and interpretation of epidemiological significance (29, 30). Faster gener-
ation of these results will allow earlier vaccination responses and containment of virus
spread, which can have a substantially greater impact on poliomyelitis cases during an
outbreak (31). Immediate availability of the poliovirus sequence allows potential sam-
ple contamination to be assessed and prevented—a challenge faced by direct detec-
tion methods relying on quantitative PCR, which requires subsequent additional PCR
and sequencing reactions.
The high sensitivity of nested entire capsid/VP1 PCR for poliovirus in stool samples
FIG 5 Polioviruses detected in Pakistan ES samples by cell culture or direct PCR followed by sequencing using three
different methods. Direct detection of poliovirus in 36 environmental samples by nested PCR and nanopore
sequencing compared with Illumina sequencing of the nested PCR product, serotype-specific PCR, and Sanger
sequencing (“Sanger”) or Sanger sequencing of cell culture isolates (up to 6 flasks per sample). A black cell indicates
detection of the virus. Sabin-related detections have been clarified as either Sabin (S) or VDPVs where possible. For
Sanger and Illumina results, gray indicates the detection of Sabin poliovirus and the possibility of a VDPV based
on multiple peaks and SNP analysis, respectively. For nanopore results, gray indicates detection of the virus but at
a low read threshold.
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has been previously reported (100% sensitivity for 84 stool extracts) (4). Combining this
approach with barcoded VP1 primers and nanopore sequencing allows sequencing of
poliovirus mixtures and avoids the problem of nonspecific amplification of NPEVs by
the Q8/Y7 primers reported in reference 4 since any such amplicons are correctly
classified as NPEVs by nanopore (unlike Sanger) sequencing.
While previous studies have successfully used Nanopore sequencing to target
specific enteroviruses (32–34), the use of pan-EV and pan-PV primers allows mixtures of
polioviruses and of polioviruses with other enteroviruses in stool and ES samples to be
identified. In artificial mixtures, the distribution of sequencing reads was found to
match the known composition of the mixture. Currently, identification of poliovirus
mixtures requires laborious testing using multiple culture flasks, plaque isolation, or
antibody blocking of specific serotypes (35). Nanopore sequencing of ES samples gave
results that were consistent with current culture-based methods but detected fewer
polioviruses overall. This may reflect the much smaller aliquot of sewage concentrate
(200 l) undergoing RNA extraction compared with that inoculated in cell culture
flasks (6 flasks with 0.5 ml each). Indeed, testing the same RNA extract with RT-PCR
using serotype-specific primers gave almost identical results and sequences to the
nested PCR and nanopore sequencing, indicating that viruses within that aliquot were
accurately and sensitively identified. Furthermore, the current cell culture algorithm
typically finds discordant results among flasks (36), in part due to a heterogenous
distribution of viruses within samples. This suggests that testing multiple aliquots or
achieving a greater sewage concentration would increase the sensitivity of direct
molecular detection methods used to test ES samples.
Nanopore sequencing using MinION has a number of advantages over alternative
next-generation sequencing approaches, which can also be applied to both culture super-
natants and PCR products. These advantages include lower initial investment and running
costs and greater portability and ease of use. This has facilitated rapid training and
implementation in laboratories using this technology for the first time. In addition, gener-
ation of full-length reads allows shared mutations to be identified along the VP1 region,
which is especially important for ES samples that may contain mixtures of polioviruses and
FIG 6 Relatedness of wild-type poliovirus 1 identified in ES samples in Pakistan using alternative
methods. Consensus VP1 sequences derived by each sequencing platform (Sanger, MiSeq, and nano-
pore) are shown in addition to the VP1 sequences of corresponding culture isolates (L20B and RD,
labeled according to cell line used in isolation). No wild-type poliovirus 1 sequence was isolated by
culture for sample M007-23; hence, an isolate from a sample taken 2 months prior from the same ES site
was used in the analysis (starred sequence).
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where short reads often cannot distinguish multiple Sabin-related viruses. A more detailed
analysis of isolates using the genome-length pan-PV primer set would even allow the
identification of viral recombination between polioviruses and human Enterovirus C sero-
types, as the primer binding sites fall within shared nonstructural regions of the genome.
The nested PCR and nanopore sequencing protocol can be scaled up to allow for the
processing of multiple samples simultaneously. While generating data for this article,
groups of up to 96 samples were run together on a single MinION flow cell. This level
of multiplexing still produced 15,000 reads per sample after just 4 hours of sequenc-
ing (using an R9.4.1 flow cell). Currently, the MinION flow cell chemistry can accom-
modate 48 hours of sequencing, and therefore, a single flow cell could in principle
sequence 500 samples. In practice, we typically sequenced 200 samples with a
tail-off due to pore degradation.
The nested PCR and nanopore sequencing protocol has a number of limitations. First,
individual sequence reads on the MinION are error prone (currently 5% single-molecule
error rate for R9 MinION flowcell). An accurate consensus can be generated from just 50
reads or more, but for samples containingmixtures of closely related polioviruses (i.e., Sabin
and VDPV of the same serotype), an initial clustering step is required. Our current bioin-
formatics pipeline was able to achieve an accurate identification of Sabin, vaccine-derived,
FIG 7 Illustration of RAMPART display for data from four ES samples. Top (left to right): (i) summary of coverage across the genome for all samples, amplicons,
and genes of poliovirus; (ii) number of mapped reads plotted against time; (iii) number of mapped reads for each sample, with unassigned reads shown in gray;
and (iv) heatmap showing the proportion of reads for each sample that map to either wild-type poliovirus, Sabin-related poliovirus or NPEVs or do not map
(“unmapped”). Bottom: detailed information is be displayed for each sample. The panel header indicates the sample that has been processed, the rate of data
processing, and the number of reads that have been mapped. Middle (left to right): (i) coverage across the genome and sample composition are displayed;
(ii) read length distribution is shown, with a peak at 1,200 bases, the expected amplicon size; (iii) coverage of genome over time, which plateaus at 12.5% given
that the amplicon spans only this proportion of the genome.
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and wild-type polioviruses in ES samples, but further validation is required. Sequencing
errors may also affect the accurate determination of sample barcodes. However, by
enforcing stringent matching criteria (double barcodes with 80% identity), we observe a
negligible misclassification of reads (0.002%). Second, a concern with repeated usage of
flow cells is carry-over from one run to the next. This can however be prevented using a
DNase wash out and alternating sets of barcoded primers that would allow any carry-over
to be identified (37). Third, our protocol generates only VP1 sequences, consistent with
current methods. However, full-genome sequences may be of interest, and amplicons for
the nearly full-length genome can be generated directly from the sample and sequenced
on a MinION device using pan-poliovirus primers (38). This PCR is less sensitive than the
nested pan-EV-VP1 protocol and in some cases may require culture-based or other meth-
ods of enrichment (e.g., see reference 39). Finally, careful handling of samples and labora-
tory processing are required to ensure optimal sensitivity and to avoid sample cross-
contamination. Further work is required to develop laboratory quality control and quality
assurance procedures, including a provision of standardized positive controls if this method
is to be adopted more widely by the Global Polio Laboratory Network. We demonstrate
however that the immediate availability of sequencing data allows identification of con-
taminants and their removal from data sets, thus minimizing false positives compared to
other direct detection methods. Further optimization of the method may also be possible,
for example through testing alternative VP1 primers that are specific to particular poliovi-
ruses (e.g., for improved detection of wild-type 1 or circulating serotype 2 VDPV in ES
samples).
In conclusion, we have developed a nested PCR with time- and cost-saving barcoded
primers that allows multiplex sample sequencing on a portable MinION sequencer. Using
this method, only quantification, sample pooling, and the addition of adaptors is required
prior to sequencing. This method was shown to be sensitive and to generate accurate
poliovirus consensus sequences from stool samples. Complex poliovirus mixtures were
identified in environmental samples, although further development of bioinformatic meth-
ods for the consistent identification of variants within ES samples is required. This method
has the potential to replace the current cell culture-based testing for poliovirus and has a
number of significant advantages over alternative direct molecular detection methods.
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